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Neurogenesis in the developing cerebral cortex of mice occurs in the dorsal telencephalon between embryonic day 11 (E11) and E17,
during which time the majority of cortical projection neurons and some glia are produced from proliferating neuroepithelial cells in the
ventricular zone. The number of cells produced by this process is governed by several factors, including cell cycle kinetics and the
proportion of daughter cells exiting the cell cycle after a given round of cell division. The in vivo effects of IGF-I on cell cycle kinetics were
investigated in nestin/IGF-I transgenic (Tg) embryos, in which IGF-I is overexpressed in the cerebral cortex and dorsal telencephalon.
These Tg mice have been shown to exhibit increased cell number in the cortical plate by E16 and increased numbers of neurons and glia
in the cerebral cortex during postnatal development. Cumulative S phase labeling with 5-bromo-2-deoxyuridine revealed a decrease in
total cell cycle length (TC ) in Tg embryos on E14. This decrease in TC was found to result entirely from a reduction in the length of the G1
phase of the cell cycle from 10.66 to 8.81 hr, with no significant changes in the lengths of the S, G2 , and M phases. Additionally, the
proportion of daughter cells reentering the cell cycle was significantly increased by 15% in Tg embryos on E14 –E15 compared with
littermate controls. These data demonstrate that IGF-I regulates progenitor cell division in the ventricular zone by reducing G1 phase
length and decreasing TC but increases cell cycle reentry.
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Introduction
Insulin-like growth factor-I (IGF-I) promotes growth and devel-
opment of the CNS (for review, see D’Ercole et al., 1996, 2002;
M. F. Anderson et al., 2002). IGF-I and its cell surface receptor,
IGF1R (the type 1 IGF receptor), are expressed throughout the
brain during embryonic development (Bondy et al., 1990, 1992;
Ayer-Le Lievre et al., 1991; Bach et al., 1991; Brooker et al., 2000).
The capacity of IGF-I to promote neuron progenitor prolifera-
tion has been documented in vitro (DiCicco-Bloom and Black,
1988; Torres-Aleman et al., 1990; Drago et al., 1991; Werther et
al., 1993; Zackenfels et al., 1995; Arsenijevic et al., 2001) and in
vivo (Ye et al., 1996; Aberg et al., 2000; O’Kusky et al., 2000;
Popken et al., 2004), but the influence of IGF-I on cell cycle
kinetics in the embryonic brain has not been studied.
The present study was conducted to investigate the in vivo
effects of IGF-I on the cell cycle kinetics of proliferating neuro-
epithelial cells in the ventricular zone (VZ) of the dorsal telen-
cephalon during embryonic development, using a line of trans-
genic (Tg) mice (nestin/IGF-I transgenics) that overexpress
IGF-I in the brain as early as embryonic day 13 (E13) (Popken et
al., 2004). Cumulative S phase labeling with 5-bromo-2-
deoxyuridine (BrdU) was used to measure several cell cycle pa-
rameters, including the growth fraction [GF (proportion of pro-
liferating cells)], total cell cycle duration [TC (mean length of the
mitotic cycle)], and individual phase lengths [TG1, TS, TG2, and
TM (lengths of the G1, S, G2, and M phases, respectively)]. In
addition, single-injection BrdU labeling protocols, combined
with double-labeling immunohistochemistry, were performed to
measure both the proliferative fraction (proportion of daughter
cells remaining in the cell cycle) and the exiting fraction (propor-
tion of daughter cells leaving the cell cycle).
Proliferating neuroepithelial cells in the VZ of the dorsal tel-
encephalon produce the vast majority of cortical projection neu-
rons, although they also give rise to some cells of glial lineage (for
review see, Parnavelas, 2000). In the subventricular zone (SVZ),
they produce predominantly glial cells, although they also give
rise to some supragranular cortical neurons (Takahashi et al.,
1995b; Tarabykin et al., 2001; Noctor et al., 2004). Cortical inter-
neurons arise predominantly from the ventral telencephalon
(S. A. Anderson et al., 1997, 1999, 2002). Neocortical neurogen-
esis in the VZ of the normal mouse extends from E11 through E17
(Takahashi et al., 1993, 1994, 1995a,b, 1996). During this time,
the mean length of the mitotic cell cycle (TC) increases approxi-
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mately twofold, attributable entirely to an increase in the length
of the G1 phase (Takahashi et al., 1995a). For proliferating neu-
roepithelial cells in the VZ, the proliferative fraction gradually
decreases, whereas the exiting fraction gradually increases, indi-
cating that initially neurons are generated slowly, and the VZ
expands rapidly (Takahashi et al., 1994, 1996). Given that the
transgene in nestin/IGF-I Tg embryos is expressed as early as E13
(Popken et al., 2004), these mice provide a unique opportunity to
study the in vivo role of IGF-I in controlling cell cycle kinetics in
the embryonic brain.
Materials and Methods
Nestin/IGF-I transgenic mice. Nestin/IGF-I Tg mice were generated at the
University of North Carolina at Chapel Hill, according to a previously
published protocol (Popken et al., 2004). Briefly, these mice carried a
transgene composed of regulatory elements that included the second
intron of the human nestin gene and the minimal promoter of herpes
simplex virus immediate early gene ICP4 (infected cell protein 4), the
human IGF-IA cDNA fused to a signal sequence from rat somatostatin,
and a sequence containing polyadenylation signals and sites derived from
the human growth hormone gene. Tg mice were generated using classical
microinjection techniques using F1 hybrid eggs from C57BL/6 and
C3/He mice. All subsequent breeding was with C57BL/6 mice, and all
mice used in these studies were derived from 15 or more generations of
matings of mice heterozygous for the transgene and C57BL/6 non-Tg
normal mice. Expression of the nestin IGF-I transgene was detectable in
the CNS as early as E13 and continued into postnatal life (Popken et al.,
2004). On E13, transgene expression was evident in the VZ of the devel-
oping telencephalic wall, whereas at later ages, transgene expression was
greatest in the cortical plate (CP) and cerebral cortex (Popken et al.,
2004). Institutional review committees of the University of British Co-
lumbia and the University of North Carolina at Chapel Hill approved all
procedures used.
Embryo collection and tissue processing. A total of 90 embryos derived
from 20 separate litters was used in the present study. Timed-pregnant
dams were generated by placing heterozygous male Tg mice with normal
C57BL/6 female mice (Charles River Laboratories, Wilmington, MA) at
8:00 A.M. Vaginal plug checks were conducted 2 hr later at 10:00 A.M.
The presence of a vaginal plug indicated conception had occurred, and
the day of conception was taken as E0. Embryo genotype was assessed by
PCR analysis of tail genomic DNA. Typically, each litter contained ap-
proximately one-half Tg and one-half non-Tg normal control embryos.
Embryos were collected from timed-pregnant dams at various gesta-
tional ages, including E11, E14, E15, E17, and E18. Individual dams were
deeply anesthetized with intraperitoneal injections of ketamine (100 mg/
kg) and xylazine (10 mg/kg). A hysterotomy was performed, and the
uterus was removed to ice cold 0.1 M PBS, pH 7.4. In the case of dams at
E11–E17, individual embryos were dissected from the uterine tissue and
decapitated, and the whole heads were placed in 70% ethanol overnight
at 4°C. E18 animals were decapitated, and the brain was dissected free of
surrounding tissue and fixed by immersion as described above. Somatic
tissue was retained for PCR analysis of embryo genotype. After fixation,
embryos were embedded in paraffin and sectioned at 4 m in the coronal
plane. Sections were collected on Colorfrost Plus glass slides (Fisher Sci-
entific, Ottawa, Ontario, Canada) and air dried.
Cumulative BrdU labeling at E14. The mean lengths of the TC and TS
were determined on E14 in Tg and control embryos using a cumulative
BrdU-labeling protocol. The GF, defined as the proportion of VZ cells
that were actively proliferating on E14 (Takahashi et al., 1993), was also
determined using this method. Details of the BrdU-labeling protocol
have been published previously (Takahashi et al., 1992, 1993, 1995a).
Briefly, pregnant mice were injected intraperitoneally with BrdU (50
g/gm body weight) beginning at 9:00 A.M. on E14. Subsequent injec-
tions were administered at maximum intervals of 3 hr, with the last BrdU
injection administered 0.5 hr before the dam was killed (Takahashi et al.,
1993). Embryos were collected at survival time points 0.5, 2.0, 3.5, 8.0,
11.0, 12.5, and 14.0 hr after the initial BrdU injection. Four animals per
group were collected at each time point, except for the 14.0 hr survival
time in which three Tg and three control embryos were sampled. In total,
54 embryos from 12 litters were used in this analysis.
Embryos were fixed and processed for paraffin embedding as de-
scribed above. Coronal sections (4 m) were stained immunohisto-
chemically for the detection of BrdU. Briefly, sections were deparaf-
finized, rehydrated in descending grades of ethanol, and incubated in 2N
HCl for 1 hr. Sections were incubated with a mouse monoclonal anti-
BrdU antibody (1:75; BD Biosciences, San Diego, CA) for 1 hr at room
temperature. After incubation with the primary antibody, sections were
processed using a Vectastain ABC Elite kit for mouse IgG (Vector Labo-
ratories, Burlingame, CA), according to the protocol of the manufac-
turer. Slides were reacted for 3 min with diaminobenzidine, cobalt chlo-
ride, and nickel ammonium sulfate and counterstained with 0.1%
aqueous basic fuchsin.
Cell counts were conducted on four nonadjacent coded histological
sections selected for each embryo at each survival time point. Details of
the counting methods used have been published previously (Takahashi et
al., 1993, 1995a). Counts were conducted in a sector of the dorsomedial
cerebral wall corresponding to the primordial primary somatosensory
cortex (see Fig. 1 A). The sector measured 100 m in its mediolateral
dimension and 4 m in its anteroposterior dimension and was posi-
tioned over a constant region of the dorsomedial cerebral wall in each
embryo. It was divided into bins, 10 m in height, that were oriented
parallel to the ventricular surface. Within each bin, BrdU-labeled and
unlabeled nuclei (see Fig. 1 D) were counted according to criteria estab-
lished by Takahashi et al. (1993). After examining the distribution of
labeled cells relative to the ventricular surface, bins 1–7 were identified as
representing the VZ in both Tg and control embryos. A labeling index
(LI) was determined for the VZ, defined as the proportion of BrdU-
labeled cells to total cells in bins 1–7.
Graphs of LI versus postinjection survival time were generated for Tg
and control embryos (see Fig. 2). For each group, a least-squares curve fit
that considered all data points from every survival time was generated
using Microsoft (Seattle, WA) Excel (Nowakowski et al., 1989). The GF
was determined as the maximum LI value attained for each group during
the experimental period. TC and TS were determined using Equations 1
and 2: (1) y-intercept  GF  TS/TC; and (2) time to reach maximum
LI  TC  TS (Takahashi et al., 1993).
The statistical significance of differences among mean LI values was
assessed using a 2  7 (groups  survival times) ANOVA of data from
the 0.5–14.0 hr survival times. Post hoc analysis of the statistical signifi-
cance of differences between individual pairs of means was conducted
using estimated marginal means with a least significant difference adjust-
ment for multiple comparisons.
Measurement of TG2M on E14. To determine the lengths of the G2 and
M phases of the cell cycle in Tg and control embryos on E14, a single-
injection BrdU-labeling protocol was used (Takahashi et al., 1993). Sin-
gle intraperitoneal injections of BrdU were administered to timed-
pregnant dams at 9:00 A.M. on E14. Dams were allowed to survive 1.0,
1.5, and 2.0 hr after injection. At the specified survival times, hysteroto-
mies were performed, and whole embryo heads were removed and fixed
by immersion in 70% ethanol overnight (n  3 per group for each sur-
vival time). Sections were processed for the detection of BrdU immuno-
reactivity as described previously. Cell counts were conducted on four
nonadjacent coded histological sections within the dorsomedial sector of
the cerebral wall equivalent to that used for the cumulative BrdU-
labeling study. Within each sector, the percentage of BrdU-labeled VZ
mitoses was determined. Mitotic figures were considered to belong to the
VZ only if they occurred within bin 1of the sector (i.e., adjacent to the
ventricular surface). The combined length of the G2 and M phases of the
cell cycle was determined as the time required to label all ventricular
mitoses with BrdU (Takahashi et al., 1993). The statistical significance
among means was assessed using a 2  3 (groups  survival times)
ANOVA.
Mitotic index estimates at E14. Estimates of mitotic index (MI), defined
as the proportion of cells in mitosis compared with the total number of
cells in the VZ, were determined in Tg and control embryos at E14.
Counts of mitotic figures were conducted on mice from the 0.5, 2.0, and
3.5 hr survival times (n  4 embryos per group for each time point)
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according to the method of Takahashi et al. (1993). Five sections adjacent to
those used for estimating TC and TS were selected from each brain. Sections
were stained with 0.1% aqueous thionine in acetate buffer, pH 3.7.
Mitotic figures were counted in the dorsomedial sector of the cerebral
wall as described previously. Counts were conducted in both hemi-
spheres of each brain. Mitotic figures falling within bin 1 were taken to
represent VZ mitoses. Abventricular mitotic figures located in bins other
than bin 1 (i.e., those mitotic cells not immediately adjacent to the ven-
tricular surface) were considered separately. The total number of cells in
the VZ (bins 1–7) was determined for each animal. MI was determined
using Equation 3: MI  Nm/Ntot, where Nm is the number of VZ mitotic
figures, and Ntot is the total number of cells in the VZ (Takahashi et al.,
1993). Estimates of TM were determined using Equation 4: TM  MI 
TC. The statistical significance among mean MI values, numbers of ven-
tricular mitoses per sector, numbers of abventricular mitoses per sector,
and numbers of cells in the VZ were assessed using 2  3 (groups 
survival times) ANOVA.
Calculation of TG1. TG1 was calculated using Equation 5: TG1  TC 
(TS  TG2M) (Takahashi et al., 1993).
Cell cycle exit at E14 –E15. The proportion of cells in the cerebral wall
that exit the cell cycle and the complementary proportion of cells that
reenter the cell cycle were assessed in Tg and control embryos on E14 –
E15. A cohort of proliferating cells was labeled with a single intraperito-
neal injection of BrdU (50 g/gm body weight) given at 9:00 A.M. on
E14. At 9:00 A.M. on E15, 24 hr later, embryos were collected (Chenn and
Walsh, 2002). For each group, three embryos were fixed by immersion in
70% ethanol, embedded in paraffin, and sectioned at 4 m in the coronal
plane.
Five nonadjacent sections (every second section in a series of 10 serial
sections) were selected from each embryo for cell counts. Slides were
processed for the immunohistochemical detection of BrdU and Ki67,
which is an endogenous marker of proliferating cells (Scholzen and Gerdes,
2000; Kee et al., 2002). Sections were deparaffinized, rehydrated, and heated
in Antigen Unmasking Solution (Vector Laboratories) for 5 min, until the
solution came to a boil. The temperature was reduced, and sections were
heated for an additional 20 min. Slides were incubated in blocking solution
(0.3% Triton X-100 and 5% normal goat serum in PBS) for 1 hr at room
temperature. Primary antibodies were diluted in blocking solution, and
slides were incubated overnight at 4°C. The primary antibodies used were
mouse monoclonal anti-BrdU (1:200; BD Biosciences) and rabbit polyclonal
anti-Ki67 (1:500; Novocastra Laboratories, Newcastle upon Tyne, UK). Pri-
mary antibody binding was detected using the fluorochrome-conjugated
secondary antibodies Alexa Fluor 488 goat anti-rabbit IgG (1:500; Molecular
Probes, Eugene, OR) and Alexa Fluor 633 goat anti-mouse IgG (1:250; Mo-
lecular Probes), which were applied to the slides for 1 hr at room temperature
in the dark. Sections were mounted in ProLong Gold antifade reagent (Mo-
lecular Probes) and dried overnight.
Immunofluorescence was detected using an Olympus Optical (Tokyo,
Japan) Fluoview 500 confocal laser scanning microscope. z-Axis optical
sections (1 m in thickness) were collected over the dorsomedial cerebral
wall. Specimens were scanned sequentially with an argon laser and a red
helium neon laser to prevent cross talk between fluorescence channels.
Differential interference contrast (DIC) images of the specimens were
collected with each scan. Scans were collected in sectors of both the right
and left hemispheres on each section (i.e., 10 scans per brain). Images
were viewed using Olympus Optical Fluoview software, and cells were
counted by hand. Within the 100  4 m sector of the dorsomedial
cerebral wall, BrdU-labeled cells were counted and scored for the pres-
ence or absence of Ki67 immunofluorescence. The proportions of BrdU-
positive/Ki67-positive (BrdU /Ki67 ) and BrdU-positive/Ki67-
negative (BrdU /Ki67 ) cells were determined for each animal (Chenn
and Walsh, 2002). The statistical significance of differences among
means was assessed using a 2  2 (groups  cell types) ANOVA. Post hoc
analysis of the statistical significance of differences between individual
pairs of means was conducted using estimated marginal means with a
least significant difference adjustment for multiple comparisons.
BrdU labeling on E11, E17, and E18. Single injections of BrdU were
administered to timed-pregnant dams on E11, E17, and E18 to determine
the duration of cortical neurogenesis during embryonic development in
Tg and control embryos. All BrdU injections (50 g/gm body weight)
were administered at 9:00 A.M., and the dam was killed 1 hr after injec-
tion. Embryos were processed as described above. Representative sec-
tions were selected and stained immunohistochemically for the detection
of BrdU with basic fuchsin as a counterstain.
Results
Cell cycle kinetics in nestin/IGF-I Tg embryos on E14
Detailed analyses of cell cycle kinetics were performed in nestin/
IGF-I Tg and control embryos on E14, which represents the mid-
point in the duration of neurogenesis in normal mice. Histolog-
ical examination revealed no signs of gross malformation or
morphological abnormalities in Tg embryos. In fact, the Tg and
control groups could not be distinguished on the basis of the size
or lamination pattern of the telencephalic wall at this age (Fig. 1).
In both groups, the thickness of the VZ was 70 m over the
dorsomedial sector being analyzed, and VZ thickness did not
appear to change over the 14.0 hr period of cumulative BrdU
labeling.
TC is reduced in Tg embryos
To determine whether IGF-I influences overall cell cycle length
during cortical neurogenesis, a cumulative BrdU-labeling proto-
col was used to generate LI values for the VZ on E14. Individual
plots of LI versus survival time for both Tg and control embryos
illustrated that LI increased linearly to a maximum value at a
Figure 1. Photomicrographs illustrating BrdU labeling in E14 control (A, C) and nestin/IGF-I
Tg (B, D) embryos 0.5 hr after injection of a timed-pregnant dam. Counts of BrdU-labeled and
unlabeled cells were conducted over the dorsomedial cerebral wall (A, black rectangle). BrdU-
labeled cells were identified by the accumulation of brown reaction product in cell bodies (D,
arrows). Unlabeled cells appear pink because of the use of a basic fuchsin counterstain. As
illustrated in the low-power photomicrographs, Tg embryos ( B) were not visually distinguish-
able from controls ( A) on E14. C and D illustrate the structure of the cerebral wall from the
ventricular surface to the pia at 9:30 A.M. on E14. The cerebral wall consisted mainly of the VZ
and SVZ in both control ( C) and Tg ( D) embryos at this time, and a morphologically distinguish-
able cortical plate was not evident in either group. The height of the VZ and the total cerebral
wall were similar in Tg and control embryos. Scale bars: A, 100 m; C, 30 m.
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given survival time and then leveled off in both groups (Fig. 2).
Maximum LI values, which are the equivalent of the GF, were
0.98 in both groups, indicating that virtually all VZ cells were
proliferating over the experimental period. The GF values for Tg
and control embryos were comparable with published values for
other strains of normal mice on E14 (Takahashi et al., 1993,
1995a; Miyama et al., 1997).
The relationship between LI and survival time was compared
between Tg and control embryos using a 2  7 ANOVA
(groups  survival times). A significant main effect of groups was
observed (F  66.568; p  0.001), indicating that LI was signifi-
cantly greater in Tg mice. Evaluation for an interaction between
groups and survival times was also significant (F  6.686; p 
0.001), allowing for direct comparisons between individual mean
LI values. LI values did not differ significantly between Tg and
control embryos at 0.5, 12.5, or 14.0 hr. However, the LI was
significantly greater in Tg embryos at 2.0 hr (16%; p  0.001), 3.5
hr (12%; p  0.001), 8.0 hr (13%; p  0.001), and 11.0 hr (7%;
p  0.001) survival times. These data indicated that, although the
proportion of cells in S phase at 0.5 hr after the initial BrdU
injection was approximately the same in Tg and control embryos,
the rate of labeling increased in Tg embryos at subsequent time
points. After reaching the inflection point in the LI versus survival
time graph, LI values leveled off in Tg and control embryos. Con-
sequently, the LI values for the 12.5 and 14.0 hr survival times did
not differ significantly between groups. However, the time re-
quired to reach the GF (i.e., TC  TS, according to Eq. 2) was
calculated to be 10.81 hr in Tg embryos and 12.66 hr in controls,
indicating that the time required to reach the GF was significantly
decreased by 1.85 hr in Tg embryos.
Individual phase lengths for TC and TS were derived from the
graphs of LI versus survival time and Equations 1 and 2, cited
above. TS was 0.2 hr (12 min) shorter in Tg embryos, indicating
that the length of S phase did not differ substantially between Tg
and control embryos (Table 1). However, TC was 2.05 hr shorter
in Tg mice (Table 1), indicating that the length of one or more
phases of the cell cycle should be reduced in Tg embryos.
TG2M is normal in Tg embryos
The combined length of the G2 and M phases of the cell cycle was
determined from single-injection BrdU experiments conducted
on E14. At postinjection survival times of 1.0, 1.5, and 2.0 hr, the
percentage of mitotic figures labeled with BrdU was determined
in Tg and control embryos (Fig. 3). A 2  3 ANOVA comparison
of the percentage of BrdU-labeled figures showed that the pro-
portion of labeled mitoses did not differ significantly between
groups (F  0.065; p  0.05). The percentage of labeled figures
was approximately the same in both groups at each survival time,
with 25% of figures labeled at 1.0 hr and 55% of figures labeled
at 1.5 hr after injection (Fig. 3). By 2.0 hr after injection, nearly
100% of mitotic figures were BrdU labeled in both Tg and control
embryos (Fig. 3). TG2M was estimated from the time required to
label all mitotic figures with BrdU, which was 2.0 hr in both
groups. Therefore, TG2M was invariant at 2.0 hr in both Tg and
control embryos. These values are consistent with previously
published reports for the value of TG2M (Takahashi et al., 1993,
1995a; Miyama et al., 1997).
Increased mitotic index in Tg embryos
MI, the proportion of mitotic figures compared with total VZ
cells, was determined on Nissl-stained sections from the 0.5, 2.0,
and 3.5 hr cumulative BrdU-labeling survival times (Eq. 3). The
mean number of cells in the VZ did not differ significantly be-
Figure 2. Plots of BrdU LIs determined by cumulative labeling with BrdU in nestin/IGF-I Tg
and control embryos on E14. The cumulative injection experiments were initiated at 9:00 A.M.,
with the final survival time point collected 14.0 hr later. LI was determined for the VZ, which was
seven bins in height for both Tg and control animals. For each group, a least-squares curve was
fit to all data points from each survival time in the analysis. The plots illustrate the linear
advance of LI toward maximum levels in Tg (filled squares, solid line) and control (open squares,
dashed line) embryos as the number of BrdU injections administered increases over the exper-
imental period. As maximum labeling is reached, LI values level off accordingly in each group.
However, LI values plateau at an earlier time in Tg embryos, indicating that LI progresses to a
maximum at a faster rate in Tg embryos and that TC  TS is reduced in Tg mice.
Table 1. Cell cycle parameters for nestin/IGF-I transgenic and normal littermate
control mice at E14
Cell cycle parameter Nestin/IGF-I transgenic (hr) Control (hr)







Mean lengths for cell cycle phases were measured using cumulative and single injection BrdU-labeling protocols.
The maximum LI attained is equivalent to the GF, which represents the proportion of actively dividing cells in the
ventricular zone.
Figure 3. Graph of the percentage of labeled mitotic figures over the dorsomedial sector of
the cerebral wall at 1.0, 1.5, and 2.0 hr after a single injection of BrdU was administered to a
timed-pregnant dam on E14 (Tg, open bars; control, filled bars). Error bars represent the SEM.
The graph shows that the percentage of labeled mitotic figures does not differ significantly
between groups at any of the times examined. By 2.0 hr after injection, essentially all mitotic
figures are labeled in Tg and control embryos. Therefore, the combined length of the G2 and M
phases is 2.0 hr in both groups.
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tween Tg (139.42 	 4.98; mean 	 SEM) and control (151.50 	
6.89) embryos, indicating that cellular density in the VZ was
similar in both groups. The mean number of ventricular mitotic
figures per sector did not differ significantly between groups (Tg,
5.208 	 0.242; control, 4.667 	 0.319; p  0.05). Similarly, the
mean number of abventricular mitotic figures per sector was not
significantly different in Tg and control embryos (Tg, 1.125 	
0.118; control, 1.117 	 0.108; p  0.05). However, analysis of the
MI data using a 2  3 ANOVA (groups  survival times) showed
a significant main effect for groups (F  7.287; p  0.015), indi-
cating that MI was significantly increased by 21% in Tg embryos
(0.382 	 0.003) compared with controls (0.314 	 0.003). The
interaction (groups  survival times) was not significant, so in-
dividual paired comparisons of mean values were not warranted.
MI data were used to calculate an estimate of TM for each
group (Eq. 4). TM values were similar in Tg and control embryos
(36.60 and 32.87 min, respectively), indicating that TM did not
differ substantially between groups. Individual estimates of TG2,
determined by subtracting TM values from 2.0 hr (TG2M), also
did not differ greatly between groups (Table 1). These data con-
firm the findings of the cumulative and single-injection BrdU
experiments. Individual estimates of TM and TG2 were not sub-
stantially different in Tg and controls, verifying the estimate of a
2.0 hr TG2M in both groups.
Reduced G1 phase length accounts for decreased TC in
Tg embryos
Data from the cumulative and single-injection BrdU experiments
demonstrated that TC was reduced in Tg embryos on E14,
whereas TS and TG2M were invariant. Using Equation 5, TG1 was
calculated in control and Tg embryos. TG1 was 1.85 hr shorter in
Tg embryos compared with controls (Table 1). This reduction in
TG1 accounts for the observed decrease in TC in Tg embryos.
Therefore, cell cycle length is reduced in Tg embryos attributable
entirely to a reduction in the length of the G1 phase of the cell
cycle.
Our control values for TC, TS, and TG1 vary slightly from
previous studies using the cumulative BrdU-labeling method
(Takahashi et al., 1993, 1995a). These variations are likely to re-
sult from the use of different strains of mice (C57BL/6 vs CD1).
However, our control data more closely resemble the values for
individual cell cycle parameters measured in CD1 mice on E15
(Takahashi et al., 1995). The value for TS calculated in this report
is longer than the value for CD1 mice determined using cumula-
tive BrdU labeling. However, our TS value is consistent with other
reports of S phase length in the rodent cortex (Atlas and Bond,
1965; Kauffman 1966, 1968; Shimada and Langman, 1970).
Nonetheless, our data clearly indicate a reduction in cell cycle
length in Tg embryos on E14.
IGF-I promotes cell cycle reentry on E14 –E15
During cortical neurogenesis, daughter cells produced by the di-
vision of progenitors within the VZ may either exit the cell cycle
and migrate from the VZ or reenter the cycle and undergo addi-
tional rounds of mitosis. One of the key factors influencing total
neuron output from the VZ is the fraction of cells that exit the cell
cycle after a given round of cell division. To better elucidate the
role of IGF-I in the decision to proliferate versus exit the cell
cycle, we determined the proportion of cells that exit the cell cycle
and the complimentary proportion that reenter the cell cycle on
E14 –E15.
Examination of single-channel images, from histological sec-
tions double stained for BrdU and Ki67 (Fig. 4), showed that
BrdU cells (red fluorescence) were located in several different
zones within the dorsomedial cerebral wall in both Tg and con-
trol embryos (Fig. 4C). BrdU cells were found within the VZ,
SVZ, and intermediate zone (IZ). Additionally, there were
BrdU cells present in the CP. Ki67 cells (Fig. 4B, green fluo-
rescence) were located predominantly within the VZ and SVZ,
and a small number of cells were found in the IZ and CP. Within
the VZ, Ki67 immunostaining was detected in the vast majority of
cells (Fig. 4B) in both Tg and control embryos. On rare instances,
a small number of Ki67 cells were observed in the VZ of some
sections; these cells likely represented newly postmitotic neurons
that had not yet completed their migrations away from the VZ.
Figure 4. Confocal microscope immunofluorescence scans of the dorsomedial cerebral wall
of a nestin/IGF-I Tg embryo at E15. Embryos were labeled with BrdU on E14 and examined 24 hr
later on E15 for the presence of BrdU (red; C–E) and Ki67 (green; B, D, E) immunostaining. DIC
images were collected with each scan to ensure that immunostaining was localized to cell
bodies ( A). All images are presented as fluorescence channels merged with corresponding DIC
images. Ki67-stained proliferating cells localized within the VZ and SVZ, as well as occasional
cells in the IZ ( B). Nearly all VZ cells were immunoreactive for Ki67. BrdU-labeled cells were
found in the VZ, SVZ/IZ, and CP ( C). Counts of BrdU /Ki67  cells (red; D, E, white arrow) and
BrdU /Ki67  cells (yellow; D, E, white asterisk) were conducted on merged images of the
green, red, and DIC channels. Scale bars: (in A) A–D, 50 m; E, 20 m.
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DIC images were examined along with fluorescence images to
ensure that immunostaining was localized within cells. Individ-
ual cell bodies were readily distinguishable on the DIC images
(Fig. 4). Double-labeled cells were identified on merged images of
the red, green, and DIC channels. These cells were characterized
by the presence of yellow punctate staining in cell bodies (Fig.
4E). Similar BrdU and Ki67 staining patterns were observed in Tg
and control embryos, and the two groups could not be easily
distinguished by visual examination alone. On each scanned im-
age, the proportions of BrdU/Ki67 and BrdU/Ki67 cells
were determined.
The mean proportions of BrdU/Ki67 and BrdU/Ki67
cells within the dorsomedial cerebral wall were compared in Tg
and control animals using a 2  2 (groups  cell types) ANOVA.
The analysis revealed a significant main effect for cell types (F 
395.137; p  0.001). The interaction term (groups  cell types)
was also significant (F  273.600; p  0.001), which warranted
comparisons of individual mean values. Individual paired com-
parisons showed that the mean proportion of BrdU/Ki67 cells
was significantly lower by 15% ( p  0.001) in Tg embryos
(0.416 	 0.004) compared with controls (0.492 	 0.005). The
mean proportion of BrdU/Ki67 cells was 15% greater ( p 
0.001) in Tg animals (0.584 	 0.004) than in controls (0.508 	
0.004). The control values for BrdU/Ki67 and BrdU/Ki67
proportions were similar to those obtained in previous studies
using these methods (Chenn and Walsh, 2002) and to previously
published cell cycle exit values, determined using alternate meth-
ods (Takahashi et al., 1996; Haydar et al., 2000).
The data obtained in the above experiments showed that the
proportion of cells returning to the cell cycle on E14 –E15 was
significantly greater in Tg embryos. Conversely, the proportion
of cells that exited the cell cycle to become postmitotic was sig-
nificantly reduced in Tg embryos, indicating that IGF-I promotes
cell cycle reentry during cortical neurogenesis on E14 –E15.
The duration of neurogenesis is normal in Tg embryos
Neurogenesis in the VZ of the developing cerebral wall typically
begins on E11 and is essentially completed by E17 in normal mice
(Takahashi et al., 1995). Embryos were collected on E11, E17, and
E18 to determine whether the duration of neurogenesis differed
between nestin/IGF-I Tg mice and controls.
On E11, the dorsomedial cerebral wall was, on average, 70 m
in thickness in both groups, measured from the ventricular sur-
face to the pia. The cerebral wall primarily consisted of a VZ and
the beginnings of a primitive plexiform zone. The VZ was 60
m thick in both Tg and control embryos (Fig. 5A,B). The den-
sity of cells in the VZ, measured as the number of profiles within
a 100-m-wide sector, did not differ significantly between Tg
embryos (119.5 	 9.5) and controls (125.5 	 6.5). Similarly, the
number of cells in the primitive plexiform zone did not differ
noticeably between groups (Fig. 5A, arrow). Ki67 immunostain-
ing revealed that these cells in the primitive plexiform zone were
not immunoreactive for Ki67 and, therefore, were assumed to be
postmitotic. BrdU labeling showed a distinct S phase zone of cells
in the VZ, which did not differ between Tg and control embryos
(Fig. 5A,B). The presence of postmitotic cells in the primitive
plexiform zone and a zone of S phase cells in the VZ indicated that
neurogenesis had begun in both groups on E11.
At 9:30 A.M. on E14, the mean radial thickness of the dorso-
medial cerebral wall, measured from ventricular surface to pia,
was 130 m in both Tg and control embryos. It consisted of a
prominent VZ, which did not differ noticeably between groups
(Fig. 5C,D). At this time, there was no evidence for a cortical plate
in either Tg or control embryos (Fig. 1C,D). By 11:00 P.M. on
E14, the average thickness of the dorsomedial cerebral wall had
increased to 230 m in Tg embryos and to 220 m in controls. A
cortical plate was evident in both groups, which did not appear to
differ between Tg and control embryos.
By E17, the area and thickness of the VZ were reduced in both
Tg and control embryos, indicating that the VZ progenitor pop-
ulation was becoming depleted and cortical neurogenesis was
nearing its endpoint (Fig. 5E,F). The height of the VZ in the
dorsomedial cerebral wall had decreased to 50 m in both
groups. BrdU labeling showed a small band of S phase cells at the
superficial margin of the VZ in both groups, as well as a very thin
band of unlabeled cells deep to this S phase band and adjacent to
the ventricular surface. These unlabeled cells had the character-
istic radially aligned appearance of VZ cells, indicating that some
neuron production was still occurring at this age (Fig. 5E,F). The
CP was visibly larger in Tg embryos on E17 (Fig. 5I–L), with no
appreciable differences in the thickness of the VZ, SVZ, or IZ.
By E18, a morphologically distinct VZ was not readily apparent
in Tg and control embryos (Fig. 5G,H). BrdU-immunoreactive cells
were observed immediately adjacent to the ventricular surface, but a
definite S phase band of cells was not distinguishable in either group
(Fig. 5G,H). The VZ appeared to be essentially replaced by randomly
oriented neuroepithelial cells, characteristic of the SVZ, and by
cuboidal ependymal cells, adjacent to the ventricular surface. These
observations indicate that neuron production from the VZ was es-
sentially completed some time between E17 and E18 in both groups.
Therefore, the overall duration of neurogenesis in the VZ during
embryonic development did not change appreciably in Tg embryos.
Discussion
The in vivo role of IGF-I in governing the dynamics of prolifera-
tion during cortical neurogenesis has not been investigated pre-
viously. In a previous report, we showed that increased expres-
sion of IGF-I in the telencephalic wall during embryonic
development and in the cerebral cortex during early postnatal
development produced increases in cortical plate volume (52%)
and total cell number (54%) in Tg embryos by E16, as well as
increases in total cortical volume (31%) and neuron number
(27%) in Tg mice by postnatal day 12 (Popken et al., 2004).
However, given that IGF-I is well documented to inhibit apopto-
sis in vitro (Bozyczko-Coyne et al., 1993; Hughes et al., 1993; Neff
et al., 1993; Mathews and Feldman, 1996; Dudek et al., 1998; Blair
et al., 1999; Yamada et al., 2001) and postnatally in vivo (Baker et
al., 1999; Chrysis et al., 2001), it was not clear to what extent, if
any, this increased cell number resulted from an IGF-I-mediated
enhancement of proliferation. Parameters that regulate neuro-
genesis and influence neuron output include cell cycle kinetics,
progenitor cell number, and the proportion of cells exiting the
cell cycle after any given division (Caviness et al., 1995; Takahashi
et al., 1996, 1997; Haydar et al., 2000; Chenn and Walsh, 2002).
The results of the present study clearly demonstrate that in-
creased expression of IGF-I reduces cell cycle length and aug-
ments progenitor cell reentry into the cell cycle during an other-
wise normal duration of cortical neurogenesis.
Our data indicate that IGF-I regulates proliferation in the VZ
corresponding to the cerebral cortex by decreasing total cell cycle
length. In general, these findings are in agreement with in vitro
studies showing that IGF-I promotes neuron proliferation
(DiCicco-Bloom and Black, 1988; Drago et al., 1991; Ye et al.,
1996; Arsenijevic et al., 2001). We also shown that IGF-I acts
specifically to reduce G1 phase length during cortical neurogen-
esis, without affecting the lengths of the G2, M, and S phases of the
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cell cycle. Early studies of IGF-I proliferative action performed
with cultured fibroblasts (BALB/c-3T3) indicate that IGF-I acts
to stimulate progression through G1 or the G0/G1 transition
(Stiles et al., 1979; Clemmons et al., 1980; Wharton et al., 1981;
Russell et al., 1984; Olashaw et al., 1987). More recent studies in
both myocytes (Reiss et al., 1997; Chakravarthy et al., 2000) and
mammary epithelial cells (Stull et al., 2002) reached the same
conclusion: that is, IGF-I promotes progression through G1
phase of the cell cycle. However, studies of estradiol-induced
mitosis in the endometrium, suggest that IGF-I regulates pro-
gression through G2 phase (Adesanya et al., 1999). It may be that
IGF-I affects proliferation differentially in specific tissues or
when its actions are coordinated with those of other agents, such
as estrogens.
The G1 phase of the cell cycle has been identified as a key
regulatory point during neurogenesis in the mouse cortex (Taka-
hashi et al., 1995a; Caviness et al., 1999). In the course of normal
cortical neurogenesis, the length of G1 increases significantly
from E11 to E17 as progenitors undergo successive cell cycles,
whereas the lengths of other phases are constant. Consequently,
TC increases over the period of neurogenesis (Takahashi et al.,
1995a).
The observed increase in MI (the proportion of mitotic figures
in the VZ) in Tg embryos on E14 resulted from the reduction in
TC with no corresponding decrease in TM. The number of cells in
M phase at any given time is proportional to TM/TC. Because TC
is reduced in Tg embryos and TM is invariant, TM accounts for a
greater fraction of total cell cycle length. Thus, at any given point
Figure 5. Representative photomicrographs of the dorsomedial cerebral wall at E11, E14, E17, and E18 in control (A, C, E, G) and nestin/IGF-I Tg (B, D, F, H ) embryos. Embryos were labeled with
BrdU and killed at 1 hr after injection. At E11, the cerebral wall consisted of the VZ and an adjacent zone of postmitotic cells (A, arrow). By E14, the SVZ was apparent adjacent to the VZ (C, D). The
height of the VZ did not differ between Tg ( D) and control ( C) embryos. A distinct zone of BrdU-labeled cells was apparent in the VZ, indicating that progenitors were actively proliferating. At E17,
the VZ was reduced in height compared with E14 embryos in both control ( E) and Tg ( F) embryos, but a zone of BrdU-labeled cells in S phase was still evident. Therefore, neurogenesis was still
occurring at E17, but the reduced height of the VZ suggested that this process was nearing completion. Increased neuron output from the VZ was apparent in control (I, K ) and Tg (J, L) embryos at
E17, because the IZ and CP were increased in size by this age. By E18, a distinct VZ was not apparent in either control ( G) or Tg ( H ) embryos. BrdU labeling showed random staining in the cells adjacent
to the ventricular surface, which were likely ependymal cells. Nestin/IGF-I Tg embryos were visibly larger than control embryos by E17 (I, control; J, Tg). Closer examination of histological sections
showed that the cortical plate was much larger in Tg embryos ( L) compared with controls ( K). Scale bars: A, C, E, G, 20 m; I, 100 m; K, 70 m.
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in time the probability of detecting mitotic figures is increased in
Tg embryos, and the MI increases accordingly. The shortened cell
cycle in Tg embryos, therefore, explains the observed increase in
MI on E14.
From cumulative BrdU-labeling experiments, we were able to
measure GF, which represents the proportion of actively prolif-
erating cells within the VZ on E14. Neuron output from the VZ
may be influenced by alterations in GF. For example, a reduction
in GF may result in diminished neuron production because fewer
progenitor cells are actively proliferating (Haydar et al., 2000).
Consistent with previously published observations (Takahashi et
al., 1993, 1995; Miyama et al., 1997), we have shown that, on E14,
essentially all cells in the VZ are proliferating in Tg and control
embryos.
Neuron output from the proliferative zones of the developing
cerebral wall is primarily dependent on the proportion of cells
that exits the mitotic cycle after any given cell division (Takahashi
et al., 1994, 1996, 1997; Caviness et al., 1995, 1999). Early in
neurogenesis, relatively few cells exit the cell cycle as postmitotic
neurons, which results in expansion of the VZ progenitor popu-
lation. As neurogenesis progresses, the fraction of cells leaving the
cycle exceeds 0.5, and the progenitor population becomes de-
pleted as neuron output increases (Takahashi et al., 1996). Our
data indicate that progression to the critical value of 0.5 that
signals the shift from progenitor expansion to depletion is de-
layed in Tg embryos as more cells reenter the proliferative cycle
on E14 –E15. These data support the results from our previous
study showing that the combined volume of VZ and SVZ was
significantly increased by 26% in Tg embryos at E16 (Popken et
al., 2004). Together, these data suggest that cells are retained in
the cell cycle during cortical neurogenesis in Tg embryos. As
more cells reenter the cycle in Tg embryos, the progenitor popu-
lation expands and the potential for the production of greater
numbers of neurons is increased.
Mathematical models of neurogenesis in the mouse cerebral
cortex predict that decreases in the exiting fraction of cells lead to
increased tangential expansion of the VZ, which results in greater
total neuron output from this zone (Caviness et al., 1995, 1999,
2003; Takahashi et al., 1997). Consequently, increases in cortical
thickness and total neuron number are predicted in the adult
(Caviness et al., 2003). Our findings of increased cell cycle reentry
at E14 –E15, greater VZ/SVZ volume at E16, and increased corti-
cal thickness (10%) and neuron number (27%) postnatally in Tg
mice (Popken et al., 2004) closely match and are further sup-
ported by these mathematical models.
There was no evidence of alterations in the duration of neu-
rogenesis in Tg embryos. Proliferating cells in the VZ appeared at
approximately E11 and disappeared by E17–E18 in both Tg and
control embryos. Our finding that neurogenesis in Tg embryos is
of normal duration indicates that IGF-I overexpression does not
override intrinsic factors governing the developmental length of
this interval or increase the lifespan of progenitors in the VZ.
Recently, it has been suggested that a proportion of radial glial
progenitor cells from the VZ are retained at the ventricular sur-
face into postnatal life, acting as neural stem cells (Tramontin et
al., 2003). Unfortunately, the methods used in the present study
did not permit an investigation of the effects of IGF-I on radial
glial transformation and stem cell survival in the adult.
Neocortical neurogenesis in the VZ of the normal mouse ex-
tends from E11 through E17 and involves an average of 11 cell
cycles (Takahashi et al.,1995a). The increase in neuron number in
the cerebral cortex of nestin/IGF-I Tg mice (Popken et al., 2004)
most likely results from an increase in the number of cell cycles
completed by progenitors during neurogenesis and/or from the
observed reduction in cell cycle exit. Although we have not mea-
sured cell cycle number experimentally, an increase in the num-
ber of cycles beyond the normal 11 in mice (Takahashi et al.,
1995a) is theoretically possible given the 2.05 hr reduction in TC
and the retention of progenitors in the cell cycle in Tg embryos.
For example, Haydar et al. (2000) have shown that delayed neu-
rogenesis and microencephaly in embryos with trisomy 16 re-
sulted from only 10 cell cycles, attributable to lengthening of TS
by 1.0 hr from E11 to E17. Therefore, increased cell cycle number
may act in conjunction with reduced cell cycle exit to produce the
increases in cortical neuron number documented in these Tg
mice (Popken et al., 2004).
During CNS development, IGF-I is known to act as an anti-
apoptotic factor in addition to its pro-mitotic function (Chrysis
et al., 2001; Popken et al., 2004). The incidence of apoptosis in
progenitor cells of the cerebral wall is estimated to be as low as
0.14% per day in normal mice (Haydar et al., 2000). The majority
of neuronal apoptosis in the cerebral cortex occurs during early
postnatal development (Spreafico et al., 1995; Thomaidou et al.,
1997; Verney et al., 2000). Therefore, inhibition of apoptosis by
IGF-I likely makes a relatively small contribution to neuron out-
put from the proliferative zones of the cerebral wall.
In conclusion, we found that IGF-I accelerates the cell cycle in
the developing VZ underlying the cerebral cortex by decreasing
TC and enhancing progenitor cell reentry into the mitotic cycle.
As a result of these effects, measurable increases in cell number
are apparent in the cortical plate and cerebral cortex of Tg mice
during embryonic and postnatal development.
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